Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Immix Biopharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 11 | +11 |
| Shares | 0 | 1.54M | +1.54M |
| Value | $0 | $5.47M | +$5.47M |
New holders (11)
Institutions that held Immix Biopharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Murchinson Ltd. | 695,600 | $2.48M | 0.24% |
| Lynwood Capital Management Inc. | 565,297 | $2.01M | 1.93% |
| Altium Capital Management LP | 122,388 | $436.0K | 0.12% |
| UBS Group AG | 32,649 | $116.0K | 0.00% |
| Eidelman Virant Capital | 29,856 | $103.0K | 0.04% |
| Citadel Advisors LLC | 26,474 | $94.0K | 0.00% |
| Millennium Management LLC | 20,470 | $73.0K | 0.00% |
| PVG Asset Management Corp | 20,000 | $71.2K | 0.26% |
| Two Sigma Securities, LLC | 13,173 | $47.0K | 0.01% |
| Context Capital Management, LLC | 11,532 | $41.0K | 0.00% |
| Clear Street LLC | 1,000 | $4.00K | 0.00% |
Sold out (0)
Institutions that held Immix Biopharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.